参考文献:1. Fukuda J.; Okamura K.; Ishihara K.; Mizumoto M.; Nakazawa K.; Ijima H.; Kajiwara T.; Funatsu K. Differentiation effects by the combination of spheroid formation and sodium butyrate treatment in human hepatoblastoma cell line (HepG2): a possible cell source for hybrid artificial liver. / Cell Transplant 14: 819鈥?27; 2005. CrossRef 2. Itoh M.; Abe Y.; Iwama Y.; Kimura F.; Satoh M.; Shoji M.; Takahashi J.; Toshima G.; Sasaki H.; Hiwatashi K.; Hata K. HPLC analysis of lipoproteins in culture medium of hepatoma cells: an in vitro system for screening antihyperlipidemic drugs. / Biotechnol Lett 31: 953鈥?57; 2009. CrossRef 3. Takahashi J.; Toshima G.; Matsumoto Y.; Kimura F.; Kiuchi T.; Hamada K.; Hata K. In vitro screening for antihyperlipidemic activities in foodstuffs by evaluating lipoprotein profiles secreted from human hepatoma cells. / J Nat Med 65: 670鈥?74; 2011. CrossRef 4. Wang X. M.; Wang X.; Ling B. S. J.; Evers B. M. Effect of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines. / Ann Surg 214: 922鈥?31; 1998. CrossRef
作者单位:Junichiro Takahashi (1) Fumiko Kimura (1) Mizuho Miura (1) Yuka Iwama (1) Gen Toshima (1) Keishi Hata (2)
1. Skylight Biotech Inc, 100-4 Sunada, Iijima, Akita, 011-0911, Japan 2. Akita Research Institute of Food and Brewing, 4-26 Sanuki, Araya-machi, Akita, 010-1623, Japan